subject: CHEBI:32139

object_name: neoplasm


subject: CHEBI:32139

object_name: Tumor Mass

tested_intervention: yes


subject: CHEBI:32139

object_name: cancer


subject: CHEBI:32139

object_name: Childhood Malignant Solid Neoplasm


subject: CHEBI:32139

object_name: Malignant Solid Neoplasm


subject: CHEBI:32139

object_name: Unresectable Malignant Neoplasm


subject: CHEBI:32139

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:32139

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:32139

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:32139

object_name: Neoplasm Metastasis


subject: CHEBI:32139

object_name: plasma cell myeloma


subject: CHEBI:32139

object_name: adult lymphoma


subject: CHEBI:32139

object_name: lymphoma


subject: CHEBI:32139

object_name: pediatric lymphoma


subject: UMLS:C2984520

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C2984520

object_name: clear cell renal carcinoma


subject: UMLS:C2984520

object_name: renal cell adenocarcinoma


subject: UMLS:C2984520

object_name: renal cell carcinoma


subject: CHEBI:33216

subject_name: Bisphenol A

object_name: neural tube defect


subject: CHEBI:33216

object_name: neural tube defects, susceptibility to


subject: UMLS:C0728976

subject_name: Control brand of phenylpropanolamine

object_name: glucose metabolism disease

tested_intervention: unsure


subject: UMLS:C0308718

subject_name: CONTROL veterinary product


subject: UMLS:C1550141

subject_name: control substance


subject: CHEBI:58097

object_name: Amputated structure (morphologic abnormality)


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:6916

subject_name: Mexiletine


subject: CHEBI:6916

object_name: chronic pain (diagnosis)


subject: CHEBI:6916

object_name: Chronic pain


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Advanced breast cancer


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: Urinary incontinence in children


subject: CHEBI:135530

subject_name: Solifenacin


subject: UNII:6Z3QHB00LB

subject_name: Bimiralisib

object_name: actinic keratosis


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Mycobacterium; atypical, pulmonary, tuberculous


subject: CHEBI:63611

subject_name: Moxifloxacin


subject: CHEBI:25812

subject_name: Ozone

object_name: Pneumonia caused by SARS-CoV-2


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: EXCESS LMW-DNA


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: leukemia


subject: PUBCHEM.COMPOUND:43805

object_name: childhood leukemia


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1268859

subject_name: Zinc supplement

object_name: end stage renal failure


subject: UMLS:C1268859

object_name: Chronic uremia


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: head and neck squamous cell carcinoma


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:27306

subject_name: vitamin B6

object_name: Inflammatory Response


subject: CHEBI:27306

object_name: Sepsis


subject: CHEBI:27306

object_name: Sepsis, CTCAE


subject: CHEBI:27306

object_name: Injury of kidney


subject: UMLS:C1440867

subject_name: lactoferrin, bovine

object_name: hepatic encephalopathy


subject: UNII:B2K5L1L8S9

subject_name: Surufatinib

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:183111

subject_name: Acoziborole

object_name: infection by Trypanosoma gambiense


subject: CHEBI:183111

object_name: human African trypanosomiasis


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: dilated cardiomyopathy


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Alzheimer disease type 1


subject: CHEBI:70839

object_name: Alzheimer disease


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:75005

subject_name: Tyr-Phe

object_name: Vaccine response impaired


subject: PUBCHEM.COMPOUND:86821

object_name: coronary microvascular disorder


subject: PUBCHEM.COMPOUND:86821

object_name: cardiovascular disorder


subject: CHEBI:26125

subject_name: phytosterols


subject: CHEBI:26125


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Coronavinae infectious disease


subject: CHEBI:61606

object_name: Prediabetes


subject: PUBCHEM.COMPOUND:53477767

subject_name: Hesperidin


subject: UMLS:C5444737

subject_name: Flaxseed antigen


subject: DRUGBANK:DB10708

subject_name: Flax seed


subject: CHEBI:82960

subject_name: Raltegravir

object_name: Chronic HIV infection


subject: CHEBI:31689

subject_name: Iguratimod

object_name: autoimmune thrombocytopenia


subject: CHEBI:31689

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:31689

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:89324

object_name: Stress Fracture


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842


subject: CHEBI:27300


subject: UMLS:C3537249


subject: MESH:D002136

subject_name: Calcium, Dietary


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UNII:93OG0JL22O

object_name: neuralgia


subject: UNII:93OG0JL22O

object_name: Neuropathic pain


subject: CHEBI:3374

subject_name: Capsaicin

object_name: diabetic polyneuropathy


subject: CHEBI:6078

subject_name: Ivermectin

object_name: hookworm infectious disease


subject: CHEBI:6078

object_name: ascariasis


subject: CHEBI:4964

subject_name: Factor X

object_name: congenital factor X deficiency


subject: CHEBI:4964

object_name: factor X deficiency


subject: UMLS:C0015518

subject_name: factor X


subject: UMLS:C0015518


subject: CHEBI:4670

subject_name: Dobutamine


subject: CHEBI:4670

object_name: c.surgical procedure; digestive system


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: cerebral palsy


subject: CHEBI:6887

object_name: neurodevelopmental disorder


subject: CHEBI:31859

subject_name: Modafinil


subject: CHEBI:31859


subject: UMLS:C3657751

object_name: hemophilia B


subject: UMLS:C3657751

object_name: hemophilia B leyden


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: adult glioblastoma


subject: CHEBI:79699

object_name: Adult Giant Cell Glioblastoma


subject: CHEBI:79699

object_name: Recurrent Adult Brain Neoplasm


subject: CHEBI:79699

object_name: Adult Gliosarcoma


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: anal fistula


subject: CHEBI:144903

object_name: Rectal Fistula, CTCAE


subject: CHEBI:144903

object_name: Rectal fistula


subject: CHEBI:61848


subject: CHEBI:61848


subject: CHEBI:61848


subject: PR:000013192


subject: PR:000013192


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: UniProtKB:P05142


subject: UniProtKB:P05142


subject: PR:000013551


subject: PR:000013551


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: PR:000003551


subject: PR:000003551


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: UniProtKB:P67986


subject: UniProtKB:P67986


subject: PR:000001886

subject_name: major prion protein


subject: PR:000001886


subject: PR:000001886


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000030465


subject: PR:000030465


subject: PR:000013555

subject_name: proline-rich protein 2


subject: PR:000013555


subject: PR:000013555


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: UniProtKB:P05143


subject: UniProtKB:P05143


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: PR:000032963


subject: PR:000032963


subject: UMLS:C0003289

subject_name: Antidepressive Agents

object_name: HIV infection


subject: UMLS:C0003289

object_name: substance-related disorder


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Fanconi anemia


subject: CHEBI:201431

object_name: Fanconi anemia complementation group A


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:73811

subject_name: Arg-Arg

object_name: lung disorder


subject: CHEBI:73811

object_name: respiratory system disorder


subject: CHEBI:73811

object_name: cystic fibrosis


subject: CHEBI:73811

object_name: asthma


subject: CHEBI:73811

object_name: Chronic obstructive pulmonary disease of horses


subject: CHEBI:73811

object_name: COPD, severe early onset


subject: CHEBI:73811

object_name: chronic obstructive pulmonary disease


subject: CHEBI:44915

subject_name: Propofol

object_name: paroxysmal familial ventricular fibrillation


subject: CHEBI:44915

object_name: ventricular fibrillation, paroxysmal familial, type 1


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: extrahepatic bile duct carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: malignant tumor of extrahepatic bile duct


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: CHEBI:49005

subject_name: Deferasirox

object_name: Myelodysplasia, CTCAE


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: bladder transitional cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:5847

subject_name: Raltitrexed


subject: CHEBI:174615

object_name: myotonia fluctuans


subject: CHEBI:174615

object_name: mycosis fungoides


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:66919

subject_name: Ruxolitinib


subject: CHEBI:66919


subject: CHEBI:27732

subject_name: Caffeine

object_name: Insufficient Sleep


subject: UNII:6E6VJP68KR

subject_name: AZIMILIDE DIHYDROCHLORIDE

object_name: Arrhythmia


subject: PUBCHEM.COMPOUND:60939

subject_name: Azimilide


subject: UMLS:C1314817

subject_name: azimilide dihydrochloride


subject: CHEBI:6128

subject_name: Ketoprofen

object_name: female infertility


subject: CHEMBL.COMPOUND:CHEMBL2108924

subject_name: CINNAMON

object_name: Diabetes


subject: UMLS:C0939899

subject_name: cinnamon preparation


subject: UMLS:C1172837

subject_name: Product R

object_name: cancer


subject: UMLS:C1172837

object_name: neoplasm


subject: CHEBI:44915

subject_name: Propofol

object_name: Gastrostomy site


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Refractory Primary Peritoneal Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Fallopian Tube Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Refractory Ovarian Carcinoma


subject: UNII:OL741S3N8B

subject_name: irinotecan sucrosofate


subject: UNII:OL741S3N8B

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UNII:OL741S3N8B


subject: UNII:OL741S3N8B


subject: UNII:OL741S3N8B

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: UNII:OL741S3N8B

object_name: Recurrent Fallopian Tube Carcinoma


subject: UNII:OL741S3N8B

object_name: Recurrent ovarian cancer


subject: UNII:OL741S3N8B

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: UNII:OL741S3N8B

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:41001

subject_name: Benzoylecgonine

object_name: malaria


subject: PUBCHEM.COMPOUND:251912

subject_name: Benzoyl ecgonine


subject: UMLS:C2698319

subject_name: Bacillus Calmette-Guerin Antigen


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: PR:000002994

subject_name: natural resistance-associated macrophage protein 1


subject: CHEMBL.COMPOUND:CHEMBL2109589

object_name: Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2109589

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL2109589

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2109589

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:33353

subject_name: technetium atom

object_name: lung cancer


subject: CHEBI:33353

object_name: lung neoplasm


subject: CHEBI:33353

object_name: lung carcinoma


subject: UNII:B33561JJ61

subject_name: TELAGLENASTAT HYDROCHLORIDE

object_name: NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor


subject: UNII:B33561JJ61

object_name: Unresectable Malignant Solid Neoplasm


subject: UNII:B33561JJ61

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:B33561JJ61

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5418246

subject_name: Telaglenastat Hydrochloride


subject: UMLS:C5418246


subject: UMLS:C5418246


subject: UMLS:C5418246


subject: UNII:4D6Q6HGC7Z

subject_name: Lesogaberan

object_name: Heartburn


subject: UNII:4D6Q6HGC7Z

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UMLS:C1251704

subject_name: Lidocaine Patch

object_name: opioid use


subject: UMLS:C1251704

object_name: opiate dependence


subject: UMLS:C1251704

object_name: opioid abuse


subject: UMLS:C1251704

object_name: pregnancy related


subject: UMLS:C3827166

object_name: Childhood Breast Carcinoma


subject: UMLS:C3827166

object_name: breast carcinoma


subject: UMLS:C3827166

object_name: breast cancer


subject: UMLS:C3827166

object_name: ovarian cancer


subject: UMLS:C3827166

object_name: ovarian neoplasm


subject: UMLS:C3827166

object_name: ovarian carcinoma


subject: UMLS:C3827166

object_name: prostate carcinoma


subject: UMLS:C3827166

object_name: prostate cancer


subject: UMLS:C3827166

object_name: non-small cell lung carcinoma


subject: UMLS:C3827166

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C3827166

object_name: clear cell renal carcinoma


subject: UMLS:C3827166

object_name: renal cell adenocarcinoma


subject: UMLS:C3827166

object_name: renal cell carcinoma


subject: UMLS:C3827166

object_name: colorectal carcinoma


subject: UMLS:C3827166

object_name: Solid Neoplasm


subject: UMLS:C3827166

object_name: melanoma


subject: CHEBI:8080

subject_name: Phentermine

object_name: Hypothalamic obesity


subject: CHEBI:8080

object_name: hypothalamic neoplasm


subject: CHEBI:8080

object_name: Childhood Craniopharyngioma


subject: CHEBI:8080

object_name: craniopharyngioma


subject: CHEBI:8080

object_name: Adult Craniopharyngioma


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Pancreatic carcinoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UNII:8Z28M5SX0X

subject_name: Zandelisib

object_name: diffuse large B-cell lymphoma


subject: CHEBI:229213

subject_name: Elacestrant

object_name: Advanced breast cancer


subject: CHEBI:229213

object_name: ESR1 Gene Mutation


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: acute myelomonocytic leukemia M4


subject: PUBCHEM.COMPOUND:596

object_name: erythroleukemia


subject: PUBCHEM.COMPOUND:596

object_name: acute megakaryoblastic leukemia


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685

object_name: acute monocytic leukemia


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: PUBCHEM.COMPOUND:71080313

subject_name: Volasertib


subject: PUBCHEM.COMPOUND:71080313


subject: PUBCHEM.COMPOUND:71080313


subject: PUBCHEM.COMPOUND:71080313


subject: UNII:6EM57086EA


subject: UNII:6EM57086EA


subject: UNII:6EM57086EA


subject: UNII:6EM57086EA


subject: CHEBI:24996

subject_name: lactate

object_name: hypoglycemia


subject: CHEBI:24996

object_name: Blood glucose below reference range (finding)


subject: CHEBI:24996

object_name: Hypoglycemia, CTCAE


subject: CHEBI:42111

subject_name: D-Lactic acid


subject: CHEBI:42111


subject: CHEBI:42111


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:16411


subject: CHEBI:16411


subject: MESH:D007773

subject_name: Lactates


subject: MESH:D007773


subject: MESH:D007773


subject: CHEBI:78320

subject_name: Lactic acid


subject: CHEBI:78320


subject: CHEBI:78320


subject: CHEBI:184662

object_name: proteinuria


subject: CHEBI:184662

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:184662

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:184662

object_name: Proteinuria, CTCAE 5.0


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEMBL.COMPOUND:CHEMBL256907


subject: CHEMBL.COMPOUND:CHEMBL256907


subject: CHEMBL.COMPOUND:CHEMBL256907


subject: CHEBI:63608

subject_name: Maraviroc


subject: CHEBI:63608


subject: CHEBI:63608


subject: CHEBI:63608


subject: PUBCHEM.COMPOUND:121371196

subject_name: Limertinib

object_name: small cell lung carcinoma


subject: PUBCHEM.COMPOUND:121371196

object_name: non-small cell lung carcinoma


subject: UMLS:C3641087

object_name: acute myeloid leukemia


subject: UMLS:C3641087

object_name: myeloid leukemia


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole


subject: UNII:3M6325NY1R

subject_name: Iron isomaltoside 1000

object_name: Restless legs


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: narcolepsy-cataplexy syndrome


subject: CHEBI:80961

object_name: cancer


subject: CHEBI:80961

object_name: neoplasm


subject: DRUGBANK:DB05014

object_name: colorectal cancer


subject: DRUGBANK:DB05014

object_name: colorectal carcinoma


subject: DRUGBANK:DB05014

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: metastatic colorectal cancer


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: PR:000001885

subject_name: macrophage scavenger receptor types I and II

object_name: childhood acute lymphoblastic leukemia


subject: PR:000001885

object_name: acute lymphoblastic leukemia


subject: PR:000001885

object_name: adult acute lymphoblastic leukemia


subject: GTOPDB:8088

subject_name: epratuzumab


subject: GTOPDB:8088


subject: CHEMBL.COMPOUND:CHEMBL2108404

subject_name: EPRATUZUMAB


subject: CHEMBL.COMPOUND:CHEMBL2108404


subject: UMLS:C0281743


subject: UMLS:C0281743


subject: CHEBI:15365

subject_name: Aspirin

object_name: hypertrophic cardiomyopathy


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: osteoarthritis


subject: UMLS:C0592155

subject_name: Syntocinon


subject: PR:000012100

subject_name: oxytocin-neurophysin 1


subject: PR:000012100

object_name: osteoarthritis, knee


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Menopause present (finding)


subject: UNII:L500PR95QA

object_name: Menopause


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: UNII:N02W67RKJS

object_name: epilepsy


subject: UNII:P28BIW0UTB

subject_name: FODIPIR


subject: PUBCHEM.COMPOUND:76967443

subject_name: Mangafodipir


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: poisoning


subject: CHEBI:45863

subject_name: Paclitaxel


subject: PUBCHEM.COMPOUND:284240

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:284240

object_name: thymus neoplasm


subject: UNII:2X1K91UT6N

subject_name: Alovudine F-18


subject: UNII:2X1K91UT6N


subject: CHEBI:177762

subject_name: Alovudine


subject: PR:000007563

subject_name: vascular endothelial growth factor receptor 1


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: inflammatory bowel disease 1


subject: CHEBI:4026

object_name: Crohn disease


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UNII:D7RD81HE4W


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C5690329

subject_name: COVAC-2 COVID-19 vaccine


subject: CHEBI:74705

subject_name: Met-Leu

object_name: tinea unguium


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:145374

subject_name: Enasidenib

object_name: Locally Advanced Olfactory Neuroblastoma


subject: CHEBI:145374

object_name: Locally Advanced Chondrosarcoma


subject: CHEBI:145374

object_name: Metastatic Olfactory Neuroblastoma


subject: CHEBI:145374

object_name: Chondrosarcoma metastatic


subject: CHEBI:80566

subject_name: Palifosfamide

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:80566

object_name: Ovarian germ cell cancer stage IV


subject: CHEBI:80566

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:80566

object_name: extragonadal germ cell cancer


subject: CHEBI:80566

object_name: Testis cancer recurrent


subject: CHEBI:80566

object_name: adult central nervous system germ cell tumor


subject: CHEBI:80566

object_name: Stage IV Extragonadal Non-Seminomatous Germ Cell Tumor


subject: CHEBI:80566

object_name: extragonadal nonseminomatous germ cell tumor


subject: CHEBI:80566

object_name: Stage IV Extragonadal Seminoma


subject: CHEBI:80566

object_name: extragonadal seminoma


subject: CHEBI:80566

object_name: adult teratoma


subject: CHEBI:94575

subject_name: Nifekalant

object_name: atrial fibrillation


subject: CHEBI:94575

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:94575

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Acute Pain


subject: CHEBI:42797

object_name: Neck Carcinoma


subject: CHEBI:42797

object_name: head and neck neoplasm


subject: CHEBI:42797

object_name: head and neck cancer


subject: UMLS:C2346492

subject_name: Indocyanine Green Solution

object_name: aneurysm


subject: UMLS:C2346492

object_name: heart disorder


subject: UMLS:C2346492

object_name: obesity due to congenital leptin deficiency


subject: UMLS:C2346492

object_name: obesity due to leptin receptor gene deficiency


subject: UMLS:C2346492

object_name: morbid obesity


subject: UMLS:C2346492

object_name: type 2 diabetes mellitus


subject: CHEBI:167309

subject_name: Methadone

object_name: postherpetic neuralgia


subject: UMLS:C0015491

subject_name: factor IX

object_name: severe hemophilia B


subject: UMLS:C4048712

subject_name: factor IX complex


subject: UNII:02E00T2QDE

subject_name: Eftrenonacog alfa


subject: UMLS:C0935952

subject_name: Oncophage

object_name: lung cancer


subject: UMLS:C0935952

object_name: lung neoplasm


subject: UMLS:C0935952

object_name: lung carcinoma


subject: UMLS:C0935952

object_name: non-small cell lung carcinoma


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Digestive System Signs and Symptoms


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:197268

subject_name: Tocotrienol

object_name: metastatic colorectal cancer


subject: UNII:WV3E0S3IQB

object_name: Urinary Urgency


subject: CHEBI:4495

subject_name: Diazoxide


subject: CHEBI:4495

object_name: hyperglycemia


subject: CHEBI:4495

object_name: glucose metabolism disease


subject: CHEBI:7563

subject_name: N-nicotinoylglycine


subject: CHEBI:7563


subject: CHEBI:7563


subject: MESH:D009539

subject_name: Nicotinic Acids


subject: MESH:D009539


subject: MESH:D009539


subject: UMLS:C3714626

subject_name: Nicotinic Acid Drug Class


subject: UMLS:C3714626


subject: UMLS:C3714626


subject: CHEBI:15940

subject_name: Niacin


subject: CHEBI:15940


subject: UMLS:C3536880

subject_name: Nicotinic Acid [EPC]


subject: UMLS:C3536880


subject: UMLS:C3536880


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:4636

object_name: acute myeloid leukemia


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C5706481

subject_name: HLA-A2-WT1 x CD3 RG6007


subject: UMLS:C5706481


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: CHEBI:177298

object_name: Residual Tumor


subject: CHEBI:176844

subject_name: Niraparib


subject: PUBCHEM.COMPOUND:46874763

object_name: Febrile Neutropenia, CTCAE


subject: PUBCHEM.COMPOUND:46874763

object_name: Infection of bloodstream


subject: PUBCHEM.COMPOUND:46874763

object_name: Sepsis


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: MESH:D002214

subject_name: Capsules

object_name: Deficiency of vitamin D3


subject: CHEBI:8776

subject_name: ranitidine

object_name: Trigeminal Nerve Injuries


subject: CHEBI:4636


subject: UMLS:C3661049

object_name: drug-induced dyskinesia


subject: CHEMBL.COMPOUND:CHEMBL5095278

subject_name: LORIGERLIMAB

object_name: Advanced cancer


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: Adult Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: metastatic prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: non-small cell squamous lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: melanoma


subject: CHEMBL.COMPOUND:CHEMBL5095278

object_name: skin melanoma


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: UMLS:C4764259


subject: CHEBI:28680

subject_name: Cytarabine

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:28680

object_name: Childhood Hodgkin Lymphoma


subject: UniProtKB:P0A9E0

subject_name: ARAC_ECOLI Arabinose operon regulatory protein (sprot)

object_name: lymphoma, non-Hodgkin, familial


subject: UniProtKB:P0A9E0

object_name: Adult Non-Hodgkin Lymphoma


subject: UniProtKB:P0A9E0

object_name: Childhood Non-Hodgkin Lymphoma


subject: UniProtKB:P0A9E0

object_name: Hodgkin Disease


subject: UniProtKB:P0A9E0


subject: UniProtKB:P0A9E0


subject: CHEBI:3423

subject_name: Carmustine


subject: CHEBI:3423


subject: CHEBI:17895

subject_name: Tyrosine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:17895

object_name: obesity


subject: CHEBI:17895

object_name: Obesity, CTCAE


subject: CHEBI:6538

subject_name: Loratadine

object_name: perennial allergic rhinitis


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:167574

object_name: Weight loss


subject: CHEBI:167574

object_name: Weight Loss, CTCAE


subject: UNII:60Y0GUO72B

subject_name: Olitigaltin

object_name: interstitial lung disease 2


subject: UNII:XRO4566Q4R

subject_name: INTERFERON BETA

object_name: Alzheimer disease


subject: UMLS:C0594372

subject_name: Avonex


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Prediabetes


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Rhinorrhea, CTCAE


subject: CHEBI:46195

object_name: Rhinorrhea


subject: CHEBI:46195

object_name: Sneezing, CTCAE


subject: CHEBI:46195

object_name: Sneeze


subject: CHEBI:46195

object_name: Nasal Congestion, CTCAE


subject: CHEBI:46195

object_name: Nasal congestion


subject: CHEBI:31500

subject_name: Dimetindene maleate


subject: CHEBI:31500


subject: CHEBI:31500


subject: CHEBI:31500


subject: CHEBI:31500

object_name: Upper Respiratory Infections


subject: CHEBI:31500


subject: CHEBI:31500


subject: CHEBI:135222

subject_name: Dimetindene


subject: CHEBI:135222


subject: CHEBI:135222


subject: CHEBI:135222


subject: CHEBI:135222


subject: CHEBI:135222


subject: CHEBI:135222


subject: CHEBI:8093

subject_name: Phenylephrine


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8093


subject: CHEBI:8093


subject: MESH:D013607

subject_name: Tablets


subject: MESH:D013607


subject: MESH:D013607


subject: MESH:D013607


subject: MESH:D013607


subject: MESH:D013607


subject: MESH:D013607


subject: CHEBI:3219

subject_name: Bupropion

object_name: pulmonary tuberculosis


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran

object_name: influenza


subject: CHEBI:6067

subject_name: Isotretinoin

object_name: male infertility


subject: CHEBI:6067

object_name: inability to impregnate


subject: CHEBI:6067

object_name: partial chromosome Y deletion


subject: CHEBI:6067

object_name: Klinefelter's syndrome - male with more than two X chromosomes


subject: CHEBI:6067

object_name: Klinefelter syndrome


subject: CHEBI:125427


subject: CHEBI:125427


subject: CHEBI:125427


subject: CHEBI:125427


subject: CHEBI:125427


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:17823


subject: CHEBI:15698

subject_name: Deoxycytidine

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:58008990

subject_name: Duvelisib

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:58008990

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:58008990

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: DRUGBANK:DB10504

subject_name: Avocado

object_name: obesity due to melanocortin 4 receptor deficiency


subject: DRUGBANK:DB10504

object_name: obesity


subject: DRUGBANK:DB10504

object_name: Obesity, CTCAE


subject: UNII:MC0MD9J0F4

object_name: respiratory syncytial virus infectious disease


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: enterocolitis


subject: UNII:FYS6T7F842

object_name: Enterocolitis, CTCAE


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: hematologic disorder


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Injury of kidney


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:229764

subject_name: Selinexor

object_name: Melanoma recurrent


subject: UMLS:C4687661

subject_name: Pavurutamab

object_name: Relapsed/refractory multiple myeloma


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: essential thrombocythemia


subject: UNII:Q46947FE7K

object_name: acquired polycythemia vera


subject: PUBCHEM.COMPOUND:76022323

subject_name: Idasanutlin


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:90926

subject_name: Tenofovir alafenamide

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:90926

object_name: Fatigue


subject: CHEBI:90926

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C1328138

object_name: rheumatoid arthritis


subject: CHEBI:145499

subject_name: Donepezil

object_name: autism spectrum disorder


subject: UMLS:C0162331

subject_name: Serc

object_name: Meniere disease


subject: CHEBI:35677

subject_name: Betahistine


subject: CHEBI:465284

subject_name: Ganciclovir

object_name: type 1 diabetes mellitus 1


subject: CHEBI:465284

object_name: type 1 diabetes mellitus


subject: CHEBI:45081

subject_name: Pentamidine


subject: CHEBI:45081


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:45924


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Impacted third molar tooth


subject: CHEBI:10127

subject_name: Zonisamide

object_name: nicotine dependence


subject: CHEBI:4696

subject_name: donepezil hydrochloride

object_name: Attention impaired


subject: CHEBI:145499


subject: CHEBI:131166

subject_name: Berzosertib

object_name: Metastatic Lung Small Cell Carcinoma


subject: CHEBI:131166

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:131166

object_name: Metastatic Lung Neuroendocrine Neoplasm


subject: CHEBI:131166

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:131166

object_name: Stage IVA Lung Cancer AJCC v8


subject: CHEBI:131166

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:231594

subject_name: Norgestrel

object_name: Hyperplasia of the endometrium


subject: CHEBI:30015

subject_name: L-valine residue

object_name: myocardial infarction


subject: CHEBI:30015

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:30015

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:16414

subject_name: Valine


subject: CHEBI:16414


subject: CHEBI:16414


subject: UniProtKB:Q98UK5

subject_name: MAFB_DANRE Transcription factor MafB (sprot)


subject: UniProtKB:Q98UK5


subject: UniProtKB:Q98UK5


subject: UNII:3JB47N2Q2P

subject_name: Natalizumab

object_name: inclusion body myositis


subject: UMLS:C0665297

subject_name: natalizumab


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Stage III Lung Cancer


subject: UMLS:C2346820


subject: CHEBI:7726

subject_name: octreotide

object_name: fistula; salivary duct or gland


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: lymphoid leukemia


subject: CHEBI:52172

subject_name: Nilotinib

object_name: Bone marrow transplant failure


subject: CHEBI:52172

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:52172

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:52172

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:52172

object_name: non-Hodgkin lymphoma


subject: CHEBI:145500

subject_name: thiencarbazone-methyl

object_name: exacerbation acute


subject: CHEBI:145500

object_name: COPD, severe early onset


subject: CHEBI:145500

object_name: chronic obstructive pulmonary disease


subject: CHEBI:35255

subject_name: Chloroform


subject: CHEBI:35255


subject: CHEBI:35255


subject: UMLS:C1456762

object_name: squamous cell carcinoma


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Brain Stem Glioblastoma


subject: CHEBI:22652

object_name: glioma susceptibility 1


subject: CHEBI:77655

subject_name: perindopril arginine

object_name: hypertension


subject: CHEBI:77655

object_name: Hypertension, CTCAE


subject: CHEBI:35156

subject_name: calcium salt


subject: CHEBI:35156


subject: UMLS:C0357197

subject_name: calcium salts


subject: UMLS:C0357197


subject: UMLS:C0060061

subject_name: Fansidar

object_name: Plasmodium falciparum malaria


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: peripheral vascular disease


subject: PUBCHEM.COMPOUND:155543961

object_name: peripheral arterial disease


subject: UMLS:C1099192


subject: UMLS:C1099192


subject: CHEBI:650917

object_name: malnutrition


subject: CHEBI:650917

object_name: Weight Fluctuation


subject: CHEBI:650917

object_name: Weight Change


subject: CHEBI:4046

subject_name: Cyproheptadine


subject: CHEBI:4046


subject: CHEBI:4046


subject: CHEBI:91400

subject_name: Afatinib

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:91400

object_name: rhabdomyosarcoma


subject: CHEBI:91400

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:91400

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:91400

object_name: primitive neuroectodermal tumor


subject: CHEBI:91400

object_name: peripheral primitive neuroectodermal tumor


subject: PR:000008432

subject_name: hydroxyacyl-coenzyme A dehydrogenase, mitochondrial

object_name: acute myeloid leukemia


subject: PR:000008427

subject_name: 3-hydroxyanthranilate 3,4-dioxygenase


subject: CHEBI:82717

subject_name: Tedizolid

object_name: kidney failure


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: plasma cell myeloma


subject: UMLS:C3896806


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: post operative nausea and vomiting


subject: UMLS:C0879399

subject_name: tositumomab

object_name: hepatitis B


subject: UMLS:C0879399

object_name: IMMUNE SUPPRESSION


subject: UMLS:C0879399

object_name: Decreased Immunologic Activity [PE]


subject: UMLS:C0879399

object_name: Decreased liver function


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin

object_name: Advanced Leiomyosarcoma


subject: UNII:2CN60TN6ZS

object_name: Metastatic leiomyosarcoma


subject: UNII:2CN60TN6ZS

object_name: Advanced Soft Tissue Sarcoma


subject: UNII:2CN60TN6ZS

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:2CN60TN6ZS

object_name: Metastatic Soft Tissue Sarcoma


subject: PR:000023306

object_name: carcinoma of esophagus


subject: PR:000023306

object_name: esophageal cancer


subject: PR:000023306

object_name: Childhood Esophageal Carcinoma


subject: PR:000023306

object_name: neoplasm of esophagus


subject: PR:000023306

object_name: Anastomotic Leak


subject: PR:000023306

object_name: Gastroesophageal junction cancer


subject: UniProtKB:P0AF12

subject_name: MTNN_ECOLI 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (sprot)


subject: UniProtKB:P0AF12


subject: UniProtKB:P0AF12


subject: UniProtKB:P0AF12


subject: UniProtKB:P0AF12


subject: UniProtKB:P0AF12


subject: CHEBI:31932

subject_name: olmesartan

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:31932

object_name: metabolic syndrome X


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Mania, CTCAE


subject: CHEBI:31236

object_name: Mania


subject: CHEBI:31355

subject_name: Carboplatin

object_name: choroid plexus neoplasm


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: GTOPDB:1160

subject_name: hCG

object_name: X-linked congenital generalized hypertrichosis


subject: UNII:T4RS462G19

subject_name: Almonertinib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: hepatitis C


subject: CHEBI:41774

object_name: chronic hepatitis C virus infection


subject: DRUGBANK:DB11357

subject_name: Linseed oil

object_name: Inflammation


subject: DRUGBANK:DB11357

object_name: chronic kidney disease


subject: DRUGBANK:DB11357

object_name: Complication of dialysis


subject: UNII:X6466M4LVP

subject_name: CEDIROGANT

object_name: Hepatic impairment


subject: DRUGBANK:DB18951

subject_name: Cedirogant


subject: MESH:C568346

subject_name: ClinOleic

object_name: nutritional supplement toxicity


subject: CHEBI:190706

subject_name: Ile-Leu


subject: CHEBI:63895

subject_name: ionic liquid


subject: UMLS:C0021764

subject_name: Interleukins


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: sickle cell disease


subject: CHEBI:201431

object_name: Cooley's anemia


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: UNII:3A189DH42V

subject_name: Alemtuzumab


subject: CHEBI:24433

subject_name: group

object_name: Neck Carcinoma


subject: CHEBI:24433

object_name: head and neck neoplasm


subject: CHEBI:24433

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: urothelial carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: ureter cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: ureter carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: carcinoma of urethra


subject: PUBCHEM.COMPOUND:131769963

object_name: urethra cancer


subject: PUBCHEM.COMPOUND:131769963

object_name: renal pelvis carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: malignant renal pelvis neoplasm


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: PUBCHEM.COMPOUND:21874242

subject_name: Vinflunine


subject: PUBCHEM.COMPOUND:21874242

object_name: transitional cell carcinoma


subject: PUBCHEM.COMPOUND:21874242


subject: PUBCHEM.COMPOUND:21874242


subject: PUBCHEM.COMPOUND:21874242


subject: PUBCHEM.COMPOUND:21874242


subject: PUBCHEM.COMPOUND:21874242


subject: PUBCHEM.COMPOUND:21874242


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: polyarticular juvenile idiopathic arthritis


subject: PR:000023317


subject: CHEBI:23965

subject_name: estradiol

object_name: fibromatosis


subject: CHEBI:23965

object_name: desmoid tumor


subject: CHEBI:23965

object_name: classic familial adenomatous polyposis


subject: CHEBI:23965

object_name: Adenomatous colonic polyposis


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: brain neoplasm


subject: UMLS:C3896909

object_name: Checkpoint kinase 2 gene mutation


subject: UMLS:C3896909

object_name: BRCA Gene Mutation


subject: UMLS:C3896909

object_name: BRCA1 gene mutation


subject: UMLS:C3896909

object_name: BRCA2 gene mutation


subject: UMLS:C3896909

object_name: ATM Gene Mutation


subject: UMLS:C3896909

object_name: PALB2 Gene Mutation


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:60799

subject_name: Esketamine

object_name: post-traumatic stress disorder


subject: UMLS:C0054946

subject_name: CD20 Antigens

object_name: plasma cell myeloma


subject: PR:000001289

subject_name: membrane-spanning 4-domains subfamily A member 1


subject: UNII:EL55307L15

subject_name: ANCROD

object_name: Acute Stroke


subject: UNII:EL55307L15

object_name: Acute Stroke Related to COVID-19


subject: UMLS:C0002823

subject_name: ancrod


subject: UMLS:C0002823


subject: CHEBI:71255

subject_name: Asenapine

object_name: psychosis


subject: CHEBI:71255

object_name: Nonorganic psychosis


subject: CHEBI:71255

object_name: Psychosis, CTCAE


subject: CHEBI:71256

subject_name: (R,R)-asenapine


subject: CHEBI:71256


subject: CHEBI:71256


subject: CHEBI:724125

subject_name: Methyl aminolevulinate

object_name: Differentiated vulvar intraepithelial neoplasia


subject: CHEBI:724125

object_name: vulvar intraepithelial neoplasia


subject: CHEBI:724125

object_name: Vulval intraepithelial neoplasia grade 2


subject: CHEMBL.COMPOUND:CHEMBL2108391

subject_name: HONEY

object_name: Laceration of perineum


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:185135

subject_name: Polyvidone


subject: CHEBI:8347

subject_name: Povidone-iodine


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Metastatic hepatocellular carcinoma


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:9123

subject_name: Sertraline

object_name: PANDAS


subject: PUBCHEM.COMPOUND:46874763


subject: UMLS:C0003232

subject_name: Antibiotics


subject: CHEBI:179553

subject_name: Hexyl 2-methylpropanoate


subject: CHEBI:17334

subject_name: penicillin


subject: PUBCHEM.COMPOUND:2269


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: UMLS:C0729157

subject_name: Trexan

object_name: rheumatoid arthritis


subject: UMLS:C4082693

subject_name: Salazopyrin


subject: UMLS:C3274460

subject_name: MEK 1/2 Inhibitor AS703988/MSC2015103B

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: liver carcinoma


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Progesterone Receptor Negative


subject: CHEBI:231679

object_name: Anatomic Stage 0 Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Prognostic Stage 0 Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: invasive ductal breast carcinoma


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Progesterone Receptor Negative


subject: CHEBI:231614

object_name: Anatomic Stage 0 Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Prognostic Stage 0 Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:231614

object_name: invasive ductal breast carcinoma


subject: UMLS:C2346820

object_name: Progesterone Receptor Negative


subject: UMLS:C2346820

object_name: Anatomic Stage 0 Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Prognostic Stage 0 Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C2346820

object_name: invasive ductal breast carcinoma


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: triple-negative breast carcinoma


subject: MESH:C000629782

object_name: Progesterone Receptor Negative


subject: MESH:C000629782

object_name: HER2/Neu Negative


subject: MESH:C000629782

object_name: Anatomic Stage 0 Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Prognostic Stage 0 Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: MESH:C000629782

object_name: invasive ductal breast carcinoma


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec

object_name: triple-negative breast carcinoma


subject: UNII:07730V90L6

object_name: Progesterone Receptor Negative


subject: UNII:07730V90L6

object_name: HER2/Neu Negative


subject: UNII:07730V90L6

object_name: Anatomic Stage 0 Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Prognostic Stage 0 Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:07730V90L6

object_name: invasive ductal breast carcinoma


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: eosinophilic esophagitis


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Menopausal Symptom


subject: CHEBI:16865

subject_name: Aminobutyrates


subject: UMLS:C0016904

subject_name: gamma-aminobutyric acid


subject: UNII:T472P45MG6

subject_name: Dibotermin alfa

object_name: Fused vertebrae


subject: UNII:T472P45MG6

object_name: osteoporosis


subject: UNII:T472P45MG6

object_name: Encounter due to family history of osteoporosis


subject: UNII:T472P45MG6

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:T472P45MG6

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C4287766

object_name: Locally advanced breast cancer


subject: UMLS:C1619357

subject_name: Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries

object_name: neuroendocrine neoplasm


subject: UMLS:C0939731

subject_name: Thyrox

object_name: coronary microvascular disorder


subject: UMLS:C4722834

subject_name: Ciclopirox Olamine Cream

object_name: tinea pedis


subject: CHEBI:50777

subject_name: Etonogestrel

object_name: menstrual symptoms


subject: GTOPDB:13630

subject_name: fitusiran

object_name: hemophilia B


subject: GTOPDB:13630

object_name: hemophilia B leyden


subject: UNII:GKF8S4C432

subject_name: Anlotinib

object_name: Advanced lung cancer


subject: UNII:GKF8S4C432

object_name: KRAS mutation-related tumors


subject: UNII:GKF8S4C432

object_name: Refractory Neoplasm


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:62880

subject_name: Veliparib

object_name: colon carcinoma


subject: CHEBI:62880

object_name: colorectal cancer


subject: CHEBI:62880

object_name: colon cancer


subject: CHEBI:62880

object_name: lung cancer


subject: CHEBI:62880

object_name: lung neoplasm


subject: CHEBI:62880

object_name: Stomach cancer


subject: CHEBI:62880

object_name: gastric cancer


subject: UMLS:C1831920

subject_name: ABT 888


subject: UMLS:C1831920


subject: UMLS:C1831920


subject: UMLS:C1831920


subject: UMLS:C1831920


subject: UMLS:C1831920

object_name: lung carcinoma


subject: UMLS:C1831920


subject: UMLS:C1831920


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Arthritis of knee


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: pleural neoplasm


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: peritoneal carcinomatosis


subject: CHEBI:32150

object_name: adrenal carcinoma


subject: CHEBI:32150

object_name: adrenal cortex carcinoma


subject: CHEBI:32150


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: female infertility


subject: CHEBI:28787

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:134156377

subject_name: HYDROCODONE BITARTRATE

object_name: Chronic low back pain


subject: GTOPDB:11376

subject_name: bintrafusp alfa

object_name: Advanced Soft Tissue Sarcoma


subject: GTOPDB:11376

object_name: Metastatic Childhood Soft Tissue Sarcoma


subject: GTOPDB:11376

object_name: Metastatic Soft Tissue Sarcoma


subject: CHEMBL.COMPOUND:CHEMBL4298024

subject_name: BINTRAFUSP ALFA


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: CHEMBL.COMPOUND:CHEMBL4298024


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C4086994


subject: UMLS:C1446425

subject_name: Cola antigen

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1446425

object_name: obesity


subject: UMLS:C1446425

object_name: Obesity, CTCAE


subject: UMLS:C1623185

subject_name: Cola


subject: UMLS:C1623185


subject: UMLS:C1623185


subject: UMLS:C1550678

subject_name: Water Specimen


subject: UMLS:C1550678


subject: UMLS:C1550678


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:15377


subject: CHEBI:15377


subject: CHEBI:87715

subject_name: Prasugrel


subject: CHEBI:87715

object_name: Blood Clot


subject: CHEBI:87715

object_name: thrombosis


subject: CHEBI:87715

object_name: Thrombosis of blood vessel


subject: UMLS:C5691215

object_name: hepatitis B


subject: PUBCHEM.COMPOUND:3267

subject_name: Estradiol valerate

object_name: Primary dysmenorrhea


subject: PUBCHEM.COMPOUND:13175121

subject_name: Dienogest


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:50838

subject_name: Drospirenone


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:6801

subject_name: Metformin

object_name: Peripheral arterial calcification


subject: PUBCHEM.COMPOUND:118059983

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:118059983

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:118059983

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:118059983

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:118059983

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:118059983

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:118059983

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:118059983

object_name: acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: acute coronary syndrome


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: CHEBI:59173

subject_name: Bivalirudin


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: cytomegalovirus retinitis


subject: PR:000001379


subject: UMLS:C0771537

subject_name: devil's claw preparation

object_name: osteoarthritis, hip


subject: UMLS:C0771537

object_name: osteoarthritis, knee


subject: CHEBI:78320

subject_name: Lactic acid

object_name: septic shock


subject: UMLS:C1176295

subject_name: Natrium lacticum, Homeopathic preparation


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Reperfusion Injury


subject: CHEBI:95346

subject_name: Atovaquone

object_name: medulloblastoma


subject: CHEBI:95346

object_name: childhood medulloblastoma


subject: CHEBI:95346

object_name: adult medulloblastoma


subject: CHEBI:95346

object_name: diffuse midline glioma, H3 K27M-mutant


subject: CHEBI:95346

object_name: diffuse intrinsic pontine glioma


subject: CHEBI:95346

object_name: High grade glioma


subject: CHEBI:95346

object_name: malignant glioma


subject: UMLS:C4732998

object_name: Post-Operative Pain


subject: UMLS:C1451148

object_name: diabetic kidney disease


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Hepatic Complication


subject: UMLS:C5435306

object_name: Delayed Graft Function


subject: GTOPDB:8414

subject_name: trebananib

object_name: endometrium adenocarcinoma


subject: GTOPDB:8414

object_name: endometrial serous adenocarcinoma


subject: GTOPDB:8414

object_name: endometrial adenosquamous carcinoma


subject: GTOPDB:8414

object_name: endometrial clear cell adenocarcinoma


subject: GTOPDB:8414

object_name: endometrioid stromal sarcoma


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UNII:X8Y5U6NC7E


subject: UMLS:C1541521

subject_name: AMG 386


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UMLS:C1541521


subject: UNII:DIH95YP7J3

subject_name: Ronacaleret

object_name: osteoporosis


subject: UNII:DIH95YP7J3

object_name: Encounter due to family history of osteoporosis


subject: UNII:DIH95YP7J3

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:DIH95YP7J3

object_name: Osteoporosis, CTCAE 3.0


subject: PUBCHEM.COMPOUND:53395955

subject_name: Natrecor

object_name: kidney failure


subject: PUBCHEM.COMPOUND:53395955

object_name: Renal Failure, CTCAE


subject: UMLS:C1170421


subject: UMLS:C1170421


subject: CHEBI:135919

subject_name: Nesiritide


subject: CHEBI:135919


subject: CHEBI:4670

subject_name: Dobutamine

object_name: congestive heart failure


subject: CHEBI:4670


subject: CHEBI:4670


subject: CHEBI:50693

subject_name: Milrinone


subject: CHEBI:50693


subject: CHEBI:50693


subject: UNII:2R27AB6766

subject_name: Caplacizumab

object_name: acquired thrombotic thrombocytopenic purpura


subject: CHEBI:6456

subject_name: Lidocaine

object_name: cataract


subject: CHEBI:6456

object_name: Cataract, CTCAE 3.0


subject: CHEBI:6456

object_name: Cataract, CTCAE 5.0


subject: CHEBI:6456

object_name: cataract on exam (physical finding)


subject: CHEBI:6456

object_name: disorder of orbital region


subject: CHEBI:6456

object_name: eye disorder


subject: PUBCHEM.COMPOUND:3025707

subject_name: Sunphenon

object_name: Stage I Prostate Cancer AJCC v6


subject: PUBCHEM.COMPOUND:3025707

object_name: Prostate cancer stage I


subject: PUBCHEM.COMPOUND:3025707

object_name: Stage I Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3025707

object_name: Stage I Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3025707

object_name: Stage IIA Prostate Cancer AJCC v7


subject: PUBCHEM.COMPOUND:3025707

object_name: Stage IIA Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3025707

object_name: Stage IIB Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:3025707

object_name: Stage IIB Prostate Cancer AJCC v7


subject: CHEBI:4806

subject_name: Epigallocatechin gallate


subject: CHEBI:4806


subject: CHEBI:4806


subject: CHEBI:4806


subject: CHEBI:4806


subject: CHEBI:4806


subject: CHEBI:4806


subject: CHEBI:4806


subject: UMLS:C4722510

object_name: prostate cancer


subject: UMLS:C4722510

object_name: prostate neoplasm


subject: CHEBI:16646

subject_name: carbohydrate

object_name: dehydration (Na, H2O)


subject: CHEBI:16646

object_name: Dehydration, CTCAE


subject: CHEBI:16646

object_name: Dehydration


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: chronic rhinosinusitis


subject: CHEBI:68551

subject_name: Linaclotide

object_name: Chronic constipation


subject: UMLS:C0304561

subject_name: rhubarb preparation

object_name: intracerebral hemorrhage


subject: UMLS:C0304561

object_name: recurrent pneumonia


subject: UMLS:C0304561

object_name: Lung Infection, CTCAE


subject: DRUGBANK:DB10651

subject_name: Rhubarb


subject: DRUGBANK:DB10651


subject: DRUGBANK:DB10651


subject: UNII:795J01AE70

subject_name: DEXPRAMIPEXOLE DIHYDROCHLORIDE

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5238200

subject_name: Dexpramipexole Dihydrochloride


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: COVID-19 respiratory infection


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Acute asthma


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: pneumonia


subject: CHEBI:89324

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C0358855

subject_name: Nicotine Transdermal Patch

object_name: Wound healed (finding)


subject: CHEBI:9907

subject_name: ursodiol

object_name: drug-induced liver injury


subject: UMLS:C5783941

subject_name: P2Y12 Inhibitor

object_name: peripheral vascular disease


subject: CHEBI:87715

subject_name: Prasugrel


subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat

object_name: AIDS


subject: UMLS:C5667099

subject_name: BD2-selective BET Inhibitor NUV-868

object_name: prostate cancer


subject: UMLS:C5667099

object_name: prostate carcinoma


subject: UMLS:C5667099

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5667099

object_name: Prostatic Cancer, Castration-Resistant


subject: UMLS:C5667099

object_name: castration-resistant prostate carcinoma


subject: UMLS:C5667099

object_name: pancreatic neoplasm


subject: UMLS:C5667099

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5667099

object_name: malignant pancreatic neoplasm


subject: UMLS:C5667099

object_name: ovarian cancer


subject: UMLS:C5667099

object_name: breast carcinoma


subject: UMLS:C5667099

object_name: breast cancer


subject: UMLS:C5667099

object_name: prostate neoplasm


subject: UMLS:C5667099

object_name: ovarian neoplasm


subject: UMLS:C5667099

object_name: Childhood Breast Carcinoma


subject: UMLS:C5667099

object_name: ovarian carcinoma


subject: UMLS:C5667099

object_name: breast neoplasm


subject: UMLS:C5667099

object_name: triple-negative breast carcinoma


subject: UMLS:C5667099

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:83766

subject_name: Olaparib


subject: UNII:2XLN4Y044H

subject_name: REGADENOSON

object_name: COPD, severe early onset


subject: PUBCHEM.COMPOUND:22451303

subject_name: Regadenoson


subject: CHEBI:75722

subject_name: Tramadol

object_name: opiate dependence


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: gonarthrosis; primary


subject: UMLS:C4708761

subject_name: Tenoxicam 20 mg powder for solution for injection vial


subject: PUBCHEM.COMPOUND:165411833

subject_name: PAFOLACIANINE

object_name: peritoneal carcinomatosis


subject: UNII:F7BD3Z4X8L

subject_name: Pafolacianine


subject: UMLS:C5565905

subject_name: Cytalux

object_name: digestive system cancer


subject: UMLS:C5565905


subject: UniProtKB:Q9WV70

subject_name: NOC2L_MOUSE Nucleolar complex protein 2 homolog (sprot)


subject: UniProtKB:Q9WV70


subject: PR:000011302

subject_name: nucleolar complex protein 2


subject: PR:000011302


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: Syncope Related to COVID-19


subject: PUBCHEM.COMPOUND:18319735

object_name: Syncope, CTCAE 5.0


subject: PUBCHEM.COMPOUND:18319735

object_name: Syncope


subject: PUBCHEM.COMPOUND:18319735

object_name: Irritable heart


subject: PUBCHEM.COMPOUND:18319735

object_name: Chronic Orthostatic Intolerance


subject: MESH:C000654432

object_name: type 1 diabetes mellitus 1


subject: MESH:C000654432

object_name: type 1 diabetes mellitus


subject: CHEBI:6541

subject_name: Losartan

object_name: aortic valve disease 2


subject: CHEBI:6541

object_name: aortic valve disease 1


subject: CHEBI:6541

object_name: aortic valve disease 3


subject: CHEBI:6541

object_name: thoracic aortic aneurysm


subject: CHEBI:6541

object_name: Thoracic aortic aneurysm without rupture


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Reversible pulpitis


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Guillain-Barre syndrome, familial


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UNII:3QJA87N40S

subject_name: Gadoxetic acid

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL2221312

subject_name: GADOXETIC ACID


subject: UMLS:C3883356

subject_name: Lipid Emulsion

object_name: organophosphate poisoning


subject: CHEBI:231679

subject_name: ipilimumab

object_name: malignant pleural mesothelioma


subject: CHEBI:93772

subject_name: Ispinesib

object_name: skin melanoma


subject: CHEBI:50853

subject_name: quantum dot

object_name: atopic conjunctivitis


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: UMLS:C2348288

object_name: Unresectable Esophageal Carcinoma


subject: UMLS:C2348288

object_name: Pancreatic carcinoma non-resectable


subject: UMLS:C2348288

object_name: Stomach cancer


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: CHEBI:27363


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: UMLS:C3714650


subject: UNII:T5IRO3534A

subject_name: Oncovin

object_name: Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Metastasis


subject: PUBCHEM.COMPOUND:131769963

object_name: childhood neoplasm


subject: PUBCHEM.COMPOUND:131769963

object_name: neoplastic syndrome


subject: PUBCHEM.COMPOUND:131769963

object_name: cancer or benign tumor


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:195558

subject_name: Entrectinib

object_name: lymphoproliferative syndrome


subject: CHEBI:195558

object_name: Neoplasms by Histologic Type


subject: CHEBI:195558

object_name: Primary malignant neoplasm


subject: CHEBI:195558

object_name: childhood malignant neoplasm


subject: CHEBI:195558

object_name: Malignant obstetric neoplasm


subject: CHEBI:195558

object_name: brain cancer


subject: CHEBI:195558

object_name: brain neoplasm


subject: CHEBI:195558

object_name: melanoma


subject: CHEBI:195558

object_name: glioma


subject: UMLS:C5206815

object_name: Advanced breast cancer


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: aphthous stomatitis


subject: CHEBI:63791

object_name: Oral ulcer


subject: CHEBI:35610

subject_name: antineoplastic agent

object_name: cardiovascular disorder


subject: CHEBI:35610

object_name: aneurysm


subject: CHEBI:35610

object_name: heart disorder


subject: CHEBI:4445

subject_name: Desflurane

object_name: Disorder of intraocular pressure


subject: CHEBI:4445

object_name: Intraocular Pressure


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P

object_name: acquired polycythemia vera


subject: UNII:DPT0O3T46P

object_name: myelofibrosis


subject: GTOPDB:4934

subject_name: G-CSF

object_name: neoplasm


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: cancer


subject: CHEBI:5864


subject: CHEMBL.COMPOUND:CHEMBL4802180

subject_name: RECOMBINANT HUMAN THROMBOPOIETIN


subject: CHEMBL.COMPOUND:CHEMBL4802180


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin


subject: UMLS:C0392939


subject: CHEBI:91326

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:91326

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:91326

object_name: Unresectable Solid Neoplasm


subject: CHEBI:140592

subject_name: Onalespib


subject: CHEBI:140592


subject: CHEBI:75958

subject_name: solution

object_name: Hemorrhage


subject: CHEBI:75958

object_name: brain neoplasm


subject: UMLS:C0037633

subject_name: Solutions


subject: UMLS:C0037633


subject: UMLS:C5205493

subject_name: Pucotenlimab

object_name: melanoma


subject: UMLS:C5555566

subject_name: Anti-PD-L1 Monoclonal Antibody LP002


subject: UMLS:C1176021

object_name: head and neck squamous cell carcinoma


subject: UMLS:C1176021

object_name: Recurrent disease


subject: UMLS:C5237476

subject_name: Rescue Medications

object_name: Neoplasm Metastasis


subject: UMLS:C3275286

object_name: ovarian cancer


subject: UMLS:C3275286

object_name: ovarian neoplasm


subject: UMLS:C3275286

object_name: ovarian carcinoma


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: gastric neoplasm


subject: UMLS:C3827082


subject: UNII:6XG22YQM2Z

subject_name: TIRAGOLUMAB


subject: UNII:6XG22YQM2Z

object_name: Stomach cancer


subject: UNII:6XG22YQM2Z

object_name: gastric cancer


subject: UNII:6XG22YQM2Z


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: UMLS:C4331912


subject: CHEBI:6715

subject_name: medroxyprogesterone

object_name: Menorrhagia


subject: MESH:C112940

subject_name: Progest


subject: CHEBI:174348


subject: CHEBI:6717

subject_name: Mefenamic acid


subject: UMLS:C5201268

subject_name: Ponstan Forte


subject: CHEBI:60654

subject_name: valproate

object_name: malignant mesothelioma


subject: CHEBI:168243

subject_name: Valproic acid glucuronide


subject: CHEBI:39867

subject_name: Valproic acid


subject: CHEBI:64816


subject: PUBCHEM.COMPOUND:90469070

subject_name: Descovy

object_name: Alcohol or Other Drugs use


subject: PUBCHEM.COMPOUND:90469070

object_name: substance use (history)


subject: PUBCHEM.COMPOUND:90469070

object_name: Adherence To Medication Regime


subject: PUBCHEM.COMPOUND:90469070

object_name: HIV infection


subject: CHEBI:133007


subject: CHEBI:133007


subject: CHEBI:133007


subject: CHEBI:133007


subject: CHEBI:90926

subject_name: Tenofovir alafenamide


subject: CHEBI:90926


subject: CHEBI:90926


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63717


subject: CHEBI:63717


subject: UNII:8H61Y4E29N

subject_name: Ortataxel

object_name: adult lymphoma


subject: UNII:8H61Y4E29N

object_name: lymphoma


subject: UNII:8H61Y4E29N

object_name: pediatric lymphoma


subject: CHEBI:6456

subject_name: Lidocaine

object_name: conscious sedation failure during procedure


subject: UMLS:C5575682

subject_name: Kefir antigen

object_name: plasma cell myeloma


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: monoclonal gammopathy of uncertain significance


subject: CHEBI:3213

subject_name: Bumetanide

object_name: Alzheimer disease type 1


subject: CHEBI:3213

object_name: Alzheimer disease


subject: CHEBI:31401

subject_name: Cilostazol

object_name: suppressor of tumorigenicity 3


subject: CHEBI:31401

object_name: cervical carcinoma


subject: CHEBI:31401

object_name: primary peritoneal carcinoma


subject: CHEBI:31401

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:31401

object_name: peritoneal carcinoma


subject: CHEBI:31401

object_name: Malignant Solid Neoplasm


subject: CHEBI:31401

object_name: uterine cancer


subject: CHEBI:31401

object_name: fallopian tube carcinoma


subject: CHEBI:31401

object_name: ovarian cancer


subject: CHEBI:31401

object_name: ovarian carcinoma


subject: CHEBI:31401

object_name: malignant epithelial tumor of ovary


subject: CHEBI:31401

object_name: vulva carcinoma


subject: CHEBI:45863

subject_name: Paclitaxel


subject: UMLS:C4733778

subject_name: Casein Phosphopeptide-Amorphous Calcium Phosphate

object_name: White Spot Lesion


subject: UMLS:C4682749

object_name: pancreatic neoplasm


subject: UMLS:C4682749

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4682749

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: cocaine abuse


subject: CHEBI:64356

subject_name: Pregabalin


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:136924190

object_name: Recurrent Primary Peritoneal Carcinoma


subject: PUBCHEM.COMPOUND:136924190

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Estrogen Receptor Positive


subject: CHEBI:8485

subject_name: Proparacaine

object_name: Ametropia


subject: CHEBI:8485

object_name: hyperopia


subject: CHEBI:8485

object_name: astigmatism


subject: CHEBI:8485

object_name: myopia


subject: UMLS:C5439503

subject_name: Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens only vaccine product

object_name: Acute respiratory disease


subject: UMLS:C5439503

object_name: pneumonia


subject: UMLS:C5439503

object_name: COVID-19-Associated Pneumonia


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine

object_name: Childhood Solid Neoplasm


subject: DRUGBANK:DB15803

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB15803

object_name: Solid Neoplasm


subject: DRUGBANK:DB15803

object_name: Refractory Neoplasm


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UNII:A35F525WBG

subject_name: PEMVIDUTIDE

object_name: alcohol dependence


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Low back pain


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:63791

object_name: small intestine cancer


subject: CHEBI:63791

object_name: small intestine carcinoma


subject: CHEBI:76842

object_name: acute kidney failure


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:15765

subject_name: Levodopa

object_name: asthma


subject: CHEBI:3395

subject_name: carbidopa


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: dysgerminoma of ovary


subject: CHEBI:81579

object_name: dysgerminoma


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: diffuse large B-cell lymphoma


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C3661134

object_name: Fibromyalgia, Primary


subject: CHEBI:9241

subject_name: Spironolactone

object_name: ST-elevation myocardial infarction


subject: CHEBI:9241

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:9241

object_name: Non-ST Elevated Myocardial Infarction


subject: UNII:FYS6T7F842

subject_name: Adalimumab

object_name: pouchitis


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Fall, CTCAE


subject: CHEBI:89324

object_name: Falls


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UNII:AHU547PI9H

subject_name: Ferric derisomaltose

object_name: heart failure


subject: UNII:AHU547PI9H

object_name: Iron deficiency


subject: UMLS:C5198622

object_name: bronchiectasis


subject: UMLS:C5198622

object_name: Recurrent lower respiratory tract infections


subject: PUBCHEM.COMPOUND:139600705

subject_name: Pramlintide

object_name: hypoglycemia


subject: PUBCHEM.COMPOUND:139600705

object_name: Blood glucose below reference range (finding)


subject: PUBCHEM.COMPOUND:139600705

object_name: Hypoglycemia, CTCAE


subject: PUBCHEM.COMPOUND:139600705

object_name: Evidence of previous gastric surgery


subject: CHEBI:132922

object_name: Irreversible pulpitis


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UMLS:C1590551

subject_name: Decavac (Td)

object_name: hepatitis C


subject: UMLS:C1590551

object_name: HIV infection


subject: MESH:C433226

subject_name: twinrix


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED

object_name: kidney disorder


subject: UMLS:C0919075

object_name: impaired renal function disease


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:10110


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Prostatitis category III (National Institute of Health classification)


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: Solid Neoplasm


subject: GTOPDB:4942

object_name: pediatric osteosarcoma


subject: GTOPDB:4942

object_name: Osteosarcoma


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C4763585

subject_name: Letaplimab


subject: UMLS:C4763585

object_name: lung adenocarcinoma


subject: UMLS:C4763585


subject: UMLS:C4763585


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: GTOPDB:12990

subject_name: sintilimab


subject: GTOPDB:12990


subject: GTOPDB:12990


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: diabetic macular edema


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid

object_name: peritoneal carcinomatosis


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:31547

subject_name: Eplerenone

object_name: Chronic central serous chorioretinopathy


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: herpes zoster


subject: CHEBI:3160

object_name: postherpetic neuralgia


subject: CHEBI:2639

subject_name: Amiloride

object_name: coronary artery disorder


subject: UNII:F70C5K4786

subject_name: Melphalan flufenamide

object_name: asthma


subject: UMLS:C5204509

subject_name: SMO Protein Inhibitor ZSP1602

object_name: neuroendocrine neoplasm


subject: UMLS:C5204509


subject: UMLS:C5204509

object_name: basal cell carcinoma


subject: UMLS:C5204509

object_name: skin basal cell carcinoma


subject: UMLS:C5204509

object_name: small cell lung carcinoma


subject: UMLS:C5204509

object_name: medulloblastoma


subject: UMLS:C5204509

object_name: childhood medulloblastoma


subject: UMLS:C5204509

object_name: adult medulloblastoma


subject: UMLS:C5204509

object_name: glioblastoma


subject: UMLS:C5204509

object_name: Childhood Glioblastoma


subject: UMLS:C5204509

object_name: adult glioblastoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: pulmonary large cell neuroendocrine carcinoma


subject: CHEBI:8772

subject_name: Raloxifene


subject: UNII:19J3781LPM

subject_name: Itacitinib

object_name: Steroid Refractory Graft Versus Host Disease


subject: UNII:19J3781LPM

object_name: graft versus host disease


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: HIV infection


subject: UMLS:C1832035


subject: CHEBI:6801

subject_name: Metformin

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:16349

subject_name: Citrulline

object_name: congenital heart disease


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: intestinal hypomagnesemia 1


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UNII:0T0250N43U

subject_name: peginterferon lambda-1a

object_name: hepatitis C


subject: UMLS:C4043002


subject: UMLS:C5690288


subject: UMLS:C5666848

subject_name: ASC 40

object_name: acne


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: invasive breast carcinoma


subject: UMLS:C0971731


subject: CHEBI:63633

subject_name: Triptorelin


subject: UMLS:C5782829

subject_name: ROPivacaine 0.2% injectable solution

object_name: atrial fibrillation new onset


subject: UMLS:C5782829

object_name: heart disorder


subject: UMLS:C3899707

subject_name: Carbon C 13/Nitrogen N 15-labeled Valine

object_name: High grade glioma


subject: UMLS:C3899707

object_name: malignant glioma


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: stage III Merkel cell carcinoma


subject: UNII:KXG2PJ551I

object_name: stage II Merkel cell carcinoma


subject: UNII:KXG2PJ551I

object_name: stage I Merkel cell carcinoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: CHEBI:15407

subject_name: Ephedrine

object_name: Hypotension during surgery


subject: UNII:9013DUQ28K

subject_name: Anakinra

object_name: diabetes mellitus


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Follicular lymphoma stage II


subject: CHEBI:74705

object_name: Follicle centre lymphoma, follicular grade I, II, III stage IV


subject: CHEBI:74705

object_name: Follicular lymphoma stage III


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PUBCHEM.COMPOUND:146195299

subject_name: Golcadomide


subject: PUBCHEM.COMPOUND:146195299


subject: PUBCHEM.COMPOUND:146195299


subject: UNII:29HLR8Z5BR

subject_name: GOLCADOMIDE


subject: UNII:29HLR8Z5BR


subject: UNII:29HLR8Z5BR


subject: PUBCHEM.COMPOUND:73995022

subject_name: Casein

object_name: type 2 diabetes mellitus


subject: DRUGBANK:DB10516


subject: UMLS:C0007332

subject_name: caseins


subject: DRUGBANK:DB11010

subject_name: Cod, unspecified


subject: PR:000029730

subject_name: small nuclear ribonucleoprotein-associated proteins B and B'


subject: UMLS:C3488428

subject_name: cod, unspecified preparation


subject: UMLS:C0056632


subject: UMLS:C2362561

subject_name: Gluten


subject: UMLS:C2827346

subject_name: wheat gluten extract


subject: UMLS:C0963149

subject_name: Definity

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C0963149

object_name: clear cell renal carcinoma


subject: UMLS:C0963149

object_name: renal cell adenocarcinoma


subject: UMLS:C0963149

object_name: renal cell carcinoma


subject: CHEBI:31980

subject_name: Perflutren


subject: CHEBI:31980


subject: CHEBI:31980


subject: CHEBI:31980


subject: PUBCHEM.COMPOUND:76022323

subject_name: Idasanutlin

object_name: rhabdoid tumor


subject: PUBCHEM.COMPOUND:76022323

object_name: atypical teratoid rhabdoid tumor


subject: PUBCHEM.COMPOUND:76022323

object_name: Childhood Atypical Teratoid/Rhabdoid Tumor


subject: PUBCHEM.COMPOUND:76022323

object_name: Atypical teratoid/rhabdoid tumour of central nervous system


subject: PUBCHEM.COMPOUND:76022323

object_name: central nervous system neoplasm


subject: PUBCHEM.COMPOUND:76022323

object_name: central nervous system cancer


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: anti-neutrophil cytoplasmic antibody-associated vasculitis


subject: CHEBI:8228

object_name: rapidly progressive glomerulonephritis


subject: CHEBI:8228

object_name: crescentic glomerulonephritis


subject: GTOPDB:2479

subject_name: HCl

object_name: epilepsy


subject: UMLS:C1512523

subject_name: hydrochloride


subject: UMLS:C0443985

subject_name: Flinders medical centre-7 marker


subject: CHEBI:17883

subject_name: Hydrochloric acid


subject: CHEBI:4953

subject_name: Exemestane

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:4953

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:4953

object_name: stage IA breast cancer


subject: CHEBI:4953

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Stage IIA Breast Carcinoma


subject: CHEBI:4953

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:4953

object_name: Stage IIB Breast Carcinoma


subject: CHEBI:4953

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:63633

subject_name: Triptorelin


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633


subject: CHEBI:63633

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:63633

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:63633

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:63633

object_name: Breast cancer recurrent


subject: CHEBI:63633

object_name: estrogen-receptor positive breast cancer


subject: CHEBI:63633

object_name: Progesterone receptor positive tumor


subject: UMLS:C1531654

subject_name: chlorhexidine / isopropyl alcohol

object_name: Surgical Wound Infection


subject: UMLS:C5555917

subject_name: Pamvatamig

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C5555917

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5555917

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5555917

object_name: colorectal cancer


subject: UMLS:C5555917

object_name: colorectal carcinoma


subject: UMLS:C5555917

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5555917

object_name: Stomach cancer


subject: UMLS:C5555917

object_name: gastric cancer


subject: CHEBI:90943

subject_name: Osimertinib


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:90943


subject: CHEBI:73638

subject_name: Phe-Val

object_name: Early childhood caries


subject: UMLS:C3501665

object_name: tinea unguium


subject: UMLS:C2347906

subject_name: Anpocogin


subject: UMLS:C2347906


subject: UMLS:C2347906


subject: UMLS:C2347906

object_name: Childhood Breast Carcinoma


subject: UMLS:C2347906

object_name: breast carcinoma


subject: UMLS:C2347906

object_name: breast cancer


subject: UNII:4A3702A96F

object_name: Alzheimer disease type 1


subject: UNII:4A3702A96F

object_name: Alzheimer disease


subject: DRUGBANK:DB19034

subject_name: Mevidalen


subject: DRUGBANK:DB19034


subject: CHEBI:156287

subject_name: Pidnarulex

object_name: Locally Advanced Breast Carcinoma


subject: CHEBI:156287

object_name: Unresectable HER2-Positive Breast Carcinoma


subject: CHEBI:156287

object_name: Metastatic HER2-Positive Breast Carcinoma


subject: CHEBI:156287

object_name: Unresectable Breast Carcinoma


subject: CHEBI:156287

object_name: Metastatic Breast Carcinoma


subject: CHEBI:156287

object_name: Unresectable Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:156287

object_name: Unresectable HER2-Low Breast Carcinoma


subject: CHEBI:156287

object_name: Metastatic Hormone Receptor-Positive Breast Carcinoma


subject: CHEBI:156287

object_name: Metastatic HER2-Low Breast Carcinoma


subject: CHEBI:156287

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:156287

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:156287

object_name: Unresectable Triple-Negative Breast Carcinoma


subject: CHEBI:156287

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:156287

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:156287

object_name: invasive breast carcinoma


subject: CHEBI:156287

object_name: Metastatic Malignant Solid Neoplasm


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: UMLS:C4287766


subject: CHEBI:85991

subject_name: panobinostat lactate

object_name: plasma cell myeloma


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone

object_name: Castration-Sensitive Prostate Carcinoma


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UNII:4I9I5X3Z6N

subject_name: VUDALIMAB


subject: UNII:4I9I5X3Z6N


subject: UNII:4I9I5X3Z6N

object_name: Adenocarcinoma of the prostate metastatic


subject: UMLS:C4725753

subject_name: Vudalimab


subject: UMLS:C4725753


subject: UMLS:C4725753


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: peripheral vascular disease


subject: CHEBI:31300

object_name: peripheral arterial disease


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:51450


subject: UMLS:C3712108

object_name: Compensated cirrhosis


subject: UMLS:C3713322


subject: UMLS:C3850285


subject: CHEBI:85182

subject_name: Dasabuvir


subject: UMLS:C4310002


subject: UMLS:C4310001


subject: CHEBI:94463


subject: PUBCHEM.COMPOUND:76192587

subject_name: Ombitasvir


subject: UMLS:C4033631

subject_name: sacubitril / valsartan

object_name: cardiogenic shock


subject: CHEBI:231951

object_name: Diabetes


subject: CHEBI:231951

object_name: diabetes mellitus


subject: GTOPDB:13304

subject_name: datopotamab deruxtecan

object_name: lung cancer


subject: GTOPDB:13304

object_name: lung neoplasm


subject: GTOPDB:13304

object_name: lung carcinoma


subject: GTOPDB:13304

object_name: metastatic malignant neoplasm in the brain


subject: UNII:GD2OWY1DTK

subject_name: DATOPOTAMAB DERUXTECAN


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UMLS:C4726586

subject_name: ADC DS-1062a


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C1268858

subject_name: Magnesium supplement

object_name: asthma


subject: CHEBI:35110

subject_name: magnesium monohydroxide


subject: CHEBI:35149

subject_name: magnesium hydroxide


subject: CHEBI:6637

subject_name: Nemalite


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Recurrent ovarian cancer


subject: CHEBI:61080

object_name: peritoneum cancer


subject: UMLS:C0963679


subject: UMLS:C0963679


subject: CHEBI:50859

subject_name: Bexarotene

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:50859

object_name: acute myeloid leukemia


subject: CHEBI:6015

subject_name: Isoflurane

object_name: Alzheimer disease


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:33569

subject_name: noradrenaline

object_name: Right Ventricular Dysfunction


subject: CHEBI:33569

object_name: Right Ventricular Dysfunction, CTCAE


subject: CHEBI:18357

subject_name: Norepinephrine


subject: CHEBI:18357


subject: CHEBI:4814

subject_name: Eprosartan

object_name: kidney disorder


subject: CHEBI:4814

object_name: impaired renal function disease


subject: CHEBI:8499

subject_name: Propranolol


subject: CHEBI:8499


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Wrinkled structure


subject: CHEBI:3160

object_name: Skin Wrinkling


subject: UNII:P12R69543A

subject_name: Branaplam

object_name: spinal muscular atrophy


subject: UNII:P12R69543A

object_name: proximal spinal muscular atrophy


subject: UMLS:C0359953

subject_name: bupivacaine / epinephrine

object_name: Impacted tooth


subject: UNII:40SGR63TGL

subject_name: Minodronic acid

object_name: postmenopausal osteoporosis


subject: UNII:40SGR63TGL

object_name: bone disorder


subject: UNII:40SGR63TGL

object_name: Encounter due to family history of osteoporosis


subject: UNII:40SGR63TGL

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:40SGR63TGL

object_name: Osteoporosis, CTCAE 3.0


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934

object_name: precancerous condition


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:8107

subject_name: Phenytoin

object_name: adult lymphoma


subject: CHEBI:8107

object_name: lymphoma


subject: CHEBI:8107

object_name: pediatric lymphoma


subject: CHEBI:8107


subject: CHEBI:8107

object_name: myeloproliferative neoplasm


subject: CHEBI:8107

object_name: Myelodysplasia


subject: CHEBI:8107


subject: CHEBI:8107

object_name: leukemia